XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-Based Compensation Expense Recorded in Statements of Operations The Company recorded stock-based compensation expense in the following expense categories in its accompanying statements of operations:

 

 

 

Three Months Ended

March 31,

 

(in thousands)

 

2022

 

 

2021

 

Research and development

 

$

3,200

 

 

$

1,840

 

General and administrative

 

 

3,629

 

 

 

2,046

 

 

 

$

6,829

 

 

$

3,886

 

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the periods indicated:

 

 

 

Number

of shares

 

 

Weighted

average

exercise price

per share

 

 

Weighted

average

remaining

contractual

term (years)

 

Outstanding at January 1, 2022

 

 

7,179,482

 

 

$

15.36

 

 

 

8.66

 

Granted

 

 

1,646,416

 

 

$

10.60

 

 

 

 

 

Exercised

 

 

(93,032

)

 

$

1.64

 

 

 

 

 

Forfeited

 

 

(191,849

)

 

$

17.86

 

 

 

 

 

Outstanding at March 31, 2022

 

 

8,541,017

 

 

$

14.54

 

 

 

8.70

 

Exercisable at March 31, 2022

 

 

2,285,520

 

 

$

8.08

 

 

 

7.85

 

Summary of Information about Stock Options Outstanding

The following table summarizes information about stock options outstanding at March 31, 2022 under the Plan:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Number

Outstanding

 

 

Weighted Average

Remaining

Contractual Life

(in years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Weighted

Average

Exercise

Price

 

$0.31 - $5.99

 

 

2,213,458

 

 

 

7.52

 

 

$

1.80

 

 

 

1,300,092

 

 

$

1.76

 

$6.00 - $11.72

 

 

1,625,800

 

 

 

9.88

 

 

 

10.58

 

 

 

2,250

 

 

 

10.09

 

$11.73 - $13.04

 

 

2,392,956

 

 

 

8.42

 

 

 

12.85

 

 

 

893,074

 

 

 

12.85

 

$13.05 - $31.13

 

 

607,804

 

 

 

9.48

 

 

 

20.34

 

 

 

11,469

 

 

 

15.72

 

$31.14 - $88.98

 

 

1,700,999

 

 

 

9.23

 

 

 

35.21

 

 

 

78,635

 

 

 

57.34

 

 

 

 

8,541,017

 

 

 

 

 

 

 

 

 

 

 

2,285,520

 

 

 

 

 

Schedule of Fair Value of Each Option Estimated on Date of Grant Using Weighted Average Assumptions

The fair value of each option was estimated on the date of grant using the weighted average assumptions in the table below:

 

 

 

Three months ended

March 31,

 

 

 

2022

 

 

2021

 

Expected volatility

 

 

84.57

%

 

 

117.13

%

Risk-free interest rate

 

 

1.97

%

 

 

0.76

%

Expected life (in years)

 

 

6.06

 

 

 

6.06

 

Expected dividend yield

 

 

 

 

 

 

Summary of Activity related to RSA Stock-Based Payment Awards

The following table summarizes activity related to RSA stock-based payment awards:

 

 

 

Number of

shares

 

 

Weighted-average

grant date fair

value

 

Unvested balance at January 1, 2022

 

 

611,608

 

 

$

2.29

 

Vested

 

 

(96,967

)

 

$

2.08

 

Unvested balance at March 31, 2022

 

 

514,641

 

 

$

2.33